Approval of brexucabtagene autoleucel for adults with relapsed and refractory acute lymphocytic leukemia

Noelle V Frey1

  • 1Cell Therapy and Transplant, Division of Hematology Oncology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA.

Blood
|May 4, 2022
PubMed